Find a lawyerOur capabilitiesYour careerSearch
Locations
Our capabilities
News

Select language:

Locations
Our capabilities
News

Select language:

hamburger menu showcase image
  1. Our thinking
  2. News
  3. News Search
  4. Freshfields advising AstraZeneca in acquisition of Gracell Biotechnologies Inc. furthering the AstraZeneca Cell Therapy
Freshfields advising AstraZeneca in acquisition of Gracell Biotechnologies Inc. furthering the AstraZeneca Cell Therapy

Freshfields is representing AstraZeneca in connection with its acquisition of Gracell Biotechnologies Inc., a global clinical-stage biopharmaceutical company developing innovative cell therapies for the treatment of cancer and autoimmune diseases, furthering the AstraZeneca cell therapy ambition.  The proposed acquisition will enrich AstraZeneca’s growing pipeline of cell therapies with GC012F, a novel, clinical-stage FasTCAR-enabled BCMA and CD19 dual-targeting autologous chimeric antigen receptor T-cell (CAR-T) therapy, a potential new treatment for multiple myeloma, as well as other haematologic malignancies and autoimmune diseases including systemic lupus erythematosus (SLE).  Additional information is available here.

Freshfields previously announced also advising AstraZeneca on its $1.1bn acquisition of Icosavax.

The Freshfields team is led by corporate/M&A partners Sebastian L. Fain and Zheng (Jonathan) Zhou together with senior associate Abigail G. Hathaway and associates Jenny Park, Chinyere Obi, Marvin Galloway and Ruth Levy with assistance from Ya Ma in Beijing. Counsel Jeff Jay and associates Madeleine Tavcar, Dylan O’Connor and Shannon O’Hara advised on life sciences matters; partners Nicole Foster and Sarah Ghulamhussain, counsel Stephanie Chiu and associates Lina Zhu and Meilun Chen advised on executive compensation and benefits; partners May Smith and Claude Stansbury with senior associate Rose Swaffield and associate Hannah Golden advised on tax matters; partners Mary Lehner, Simon Priddis, Jenny Leahy and Ninette Dodoo, counsel Laura Onken and associates Kristy Brown, Tim Swartz, Kara King and Haoyang Zhuo advised on competition matters; counsel Christine Laciak advised on foreign investment matters; partner Stephanie Brown Cripps and associate Marcus Levy advised on sanctions matters; partners Christine Lyon and Brock Dahl and associate Maria Paz Lestido advised on privacy and cybersecurity matters. Chinese law advice was provided by Chinese firm RuiMin, which is part of Freshfields’ StrongerTogether network of leading domestic law firms.

Our Team
New York
Sebastian L. FainPartner
New York
Zheng (Jonathan) ZhouPartner
New York
Abigail HathawaySenior Associate
New York
Jenny ParkAssociate
New York
Marvin GallowayAssociate
New York
Ruth LevyAssociate
New York
Jeff JayPartner
New York
Shannon O'HaraAssociate
FIND US IN
All locations
NAVIGATE TO
About usYour careerOur thinkingOur capabilitiesNews
CONNECT
Find a lawyerAlumniContact us
NEED HELP
Fraud and scamsComplaintsTerms and conditions
LEGAL
AccessibilityCookiesLegal noticesTransparency in supply chains statementResponsible procurementPrivacy

© 2025 Freshfields. Attorney Advertising: prior results do not guarantee a similar outcome

Select language: